VSI Fall 2022 Newsletter
Bibliography and Sources
Back to the Newsletter
Avita Medical. AVITA Medical Achieves Positive Topline Pivotal Trial Results for Treatment of Stable Vitiligo Using the RECELL® System. Avita Press Release. 2022.Sept 12.
Cobern J, Boren R. FDA approves new therapy for people living with skin-discoloration disorder vitiligo The cream treats an autoimmune condition that changes skin color.ABCNews.com. 2022.July 19.
van Geel N, Taieb A. et al. Koebner’s phenomenon in vitiligo: European position paper. Pigment Cell & Melanoma Research. Vol. 24,3 (2011): 564-73. 2011 June 24, epub 2011 Mar 7. https://pubmed.ncbi.nlm.nih.gov/21324101/
Yadav A, Yadav P, et al. Tattoo for Camouflage: A New Cause of Tattoo Regret. Indian Dermatol Online J. 11(2):250-252. 2020 Mar 9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247660/
Copyright © 2022 Vitiligo Support International Inc. All rights reserved.
Reproduction or republication strictly prohibited without prior written permission.
A Vitiligo Support International, Inc. financial statement is available upon written request from the
Virginia Office of Consumer Affairs. Mail requests to:
Virginia Department of Agriculture and Consumer Services,
Office of Consumer Affairs,
P.O. Box 1163, Richmond, Virginia 23218.